Published in Transplantation on October 27, 1997
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann Surg (2004) 1.63
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Psychiatric aspects of organ transplantation in critical care. Crit Care Clin (2008) 1.11
Morbidity of 200 consecutive cases of hand-assisted laparoscopic living donor nephrectomies: a single-center experience. J Transplant (2012) 1.01
Assessing elements of informed consent among living donors. Clin Transplant (2010) 0.96
It's only love? Some pitfalls in emotionally related organ donation. J Med Ethics (2001) 0.95
Psychosocial evaluation of candidates for living related kidney donation. Pediatr Nephrol (2006) 0.92
Thyroid surgery in octogenarians is associated with higher complication rates. Surgery (2009) 0.92
Kidney organ donation: developing family practice initiatives to reverse inertia. BMC Health Serv Res (2010) 0.91
Appraisal of GFR-estimating equations following kidney donation. Am J Kidney Dis (2009) 0.90
Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in comparison with three different techniques. World J Urol (2006) 0.85
Current trends and short-term outcomes of live donor nephrectomy: a population-based analysis of the nationwide inpatient sample. World J Surg (2010) 0.84
Live related donors in India: Their quality of life using world health organization quality of life brief questionnaire. Indian J Urol (2011) 0.83
Exploring Knowledge About Dialysis, Transplantation, and Living Donation Among Patients and Their Living Kidney Donors. Int J Behav Med (2015) 0.82
Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors? Clin Exp Nephrol (2010) 0.82
Negative pressure pulmonary edema after laparoscopic donor nephrectomy. JSLS (2013) 0.80
The oxidative effect of prolonged CO2 pneumoperitoneum on renal tissue of rats. Surg Endosc (2004) 0.80
The living kidney donor evaluation: focus on renal issues. Clin J Am Soc Nephrol (2012) 0.78
Comparative and prospective analysis of three different approaches for live-donor nephrectomy. Clinics (Sao Paulo) (2009) 0.78
Vascular constraints in laparoscopic renal allograft: comparative analysis of multiple and single renal arteries in 976 laparoscopic donor nephrectomies. World J Surg (2011) 0.77
The effect of body mass index at the time of donation on postoperative and remote consequences of nephrectomy in 189 living-related kidney donors. Arab J Urol (2015) 0.75
Living organ donation: an ethical evolution or evolution of ethics? Int J Organ Transplant Med (2010) 0.75
Evaluation of a Multimodal Approach to Postoperative Pain in Patients Undergoing Flank Incision in the Urology Operating Room. Turk J Anaesthesiol Reanim (2013) 0.75
Change in renal function following laparoscopic donor nephrectomy using 99 mTc-diethylenetriaminepentaacetic acid scan. World J Urol (2014) 0.75
Grandparent donors in paediatric renal transplantation. Pediatr Nephrol (2005) 0.75
Living-donor kidney transplantation: the Freiburg experience. Langenbecks Arch Surg (2006) 0.75
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
Circadian variation in the rejection of rat kidney allografts. Surgery (1973) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
A rapid method for purification of large quantities of anti-lymphocytic serum. Proc Soc Exp Biol Med (1967) 1.42
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet (1988) 1.38
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36
Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Protection of the donor kidney during homotransplantation. Ann Surg (1966) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Synergistic effects on DNA synthesis of phytohemagglutinin or concanavalin A and lipopolysaccharide in human peripheral blood lymphocytes. J Immunol (1975) 1.32
Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
Renal transplantation in high-risk patients. Arch Surg (1971) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Transplantation of pediatric donor kidneys to adult recipients. Is there a critical donor age? Ann Surg (1986) 1.26
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation (1994) 1.22
Mycotic aneurysms in transplant patients. Arch Surg (1976) 1.21
Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med (1976) 1.21
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
Experimental renal heterotransplantation. I. In widely divergent species. Transplantation (1966) 1.20
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19